JP2014526266A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014526266A5 JP2014526266A5 JP2014531242A JP2014531242A JP2014526266A5 JP 2014526266 A5 JP2014526266 A5 JP 2014526266A5 JP 2014531242 A JP2014531242 A JP 2014531242A JP 2014531242 A JP2014531242 A JP 2014531242A JP 2014526266 A5 JP2014526266 A5 JP 2014526266A5
- Authority
- JP
- Japan
- Prior art keywords
- gram
- composition
- positive bacterium
- trehalose
- positive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000894006 Bacteria Species 0.000 claims 25
- 239000000203 mixture Substances 0.000 claims 23
- 108090000623 proteins and genes Proteins 0.000 claims 18
- 108010011224 Trehalose 6-phosphate phosphorylase Proteins 0.000 claims 13
- 238000000034 method Methods 0.000 claims 12
- 241000192125 Firmicutes Species 0.000 claims 9
- 230000000694 effects Effects 0.000 claims 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 8
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 7
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 7
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 7
- 235000014655 lactic acid Nutrition 0.000 claims 4
- 239000004310 lactic acid Substances 0.000 claims 4
- 239000000463 material Substances 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims 3
- 235000013305 food Nutrition 0.000 claims 3
- 108020003272 trehalose-phosphatase Proteins 0.000 claims 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 2
- 241000186000 Bifidobacterium Species 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 241000194035 Lactococcus lactis Species 0.000 claims 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 2
- 235000014897 Streptococcus lactis Nutrition 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 2
- 238000007710 freezing Methods 0.000 claims 2
- 230000008014 freezing Effects 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 239000001963 growth medium Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000000069 prophylactic effect Effects 0.000 claims 2
- 238000001694 spray drying Methods 0.000 claims 2
- 238000003860 storage Methods 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 101150089952 trePP gene Proteins 0.000 claims 2
- 230000002378 acidificating effect Effects 0.000 claims 1
- 239000003833 bile salt Substances 0.000 claims 1
- 229940093761 bile salts Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000002778 food additive Substances 0.000 claims 1
- 235000013373 food additive Nutrition 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 230000003204 osmotic effect Effects 0.000 claims 1
- 230000002018 overexpression Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000006041 probiotic Substances 0.000 claims 1
- 230000000529 probiotic effect Effects 0.000 claims 1
- 235000018291 probiotics Nutrition 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11182642 | 2011-09-23 | ||
| EP11182642.6 | 2011-09-23 | ||
| PCT/EP2012/068633 WO2013041672A1 (en) | 2011-09-23 | 2012-09-21 | Modified gram positive bacteria and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014526266A JP2014526266A (ja) | 2014-10-06 |
| JP2014526266A5 true JP2014526266A5 (enExample) | 2016-06-30 |
| JP6117212B2 JP6117212B2 (ja) | 2017-04-19 |
Family
ID=47022630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014531242A Active JP6117212B2 (ja) | 2011-09-23 | 2012-09-21 | 改変されたグラム陽性菌及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9458467B2 (enExample) |
| EP (1) | EP2758512B1 (enExample) |
| JP (1) | JP6117212B2 (enExample) |
| DK (1) | DK2758512T3 (enExample) |
| ES (1) | ES2676707T3 (enExample) |
| HU (1) | HUE038830T2 (enExample) |
| WO (1) | WO2013041672A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014006883A8 (pt) * | 2011-09-23 | 2018-06-26 | Actogenix Nv | bactéria gram-positiva não patogênica carecendo de atividade do componente llc do sistema pts celobiose específico (ptcc), medicamento, aditivo alimentar, composição probiótica, ou cultura iniciadora, produto alimentar e métodos |
| CA2971520C (en) | 2014-12-23 | 2024-04-09 | Ilya Pharma Ab | Methods for wound healing |
| CN109843320A (zh) * | 2016-09-02 | 2019-06-04 | 英特瑞克斯顿阿克图比奥帝克斯有限公司 | 稳定表达il-10和胰岛素的遗传修饰的细菌 |
| RU2762940C2 (ru) | 2016-09-13 | 2021-12-24 | Интрексон Актобиотикс Н.В. | Мукоадгезивный микроорганизм |
| CN108410763B (zh) * | 2018-03-14 | 2020-10-09 | 绍兴同创生物科技有限公司 | 长双歧杆菌tc01及其应用和应用其的产品 |
| CN113481207B (zh) * | 2021-07-15 | 2023-04-07 | 西南大学 | 家蚕卵滞育的必需基因Bmtret1及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9006400D0 (en) | 1990-03-22 | 1990-05-23 | Ciba Geigy Ag | Bacterial vectors |
| US6277969B1 (en) | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
| IT1270123B (it) | 1994-10-05 | 1997-04-28 | Dompe Spa | Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia |
| GB9521568D0 (en) | 1995-10-20 | 1995-12-20 | Lynxvale Ltd | Delivery of biologically active polypeptides |
| US6033376A (en) | 1998-09-30 | 2000-03-07 | Allergan Sales, Inc. | Wound shaper sleeve |
| DE69914932T2 (de) | 1998-10-20 | 2004-12-09 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. | Verwendung eines zytokine-produzierenden lactococcus stammes zur behandlung von kolitis |
| AU781679B2 (en) | 1999-07-05 | 2005-06-09 | Intrexon Actobiotics Nv | Delivery of trefoil peptides |
| AT407730B (de) | 2000-01-14 | 2001-05-25 | Hoerbiger Hydraulik | Betätigungsanordnung für schwenkbare teile an fahrzeugen |
| GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| JP4347575B2 (ja) | 2001-05-03 | 2009-10-21 | アクトジェニックス・エヌブイ | 自己自制ラクトコッカス（Ｌｏｃｔｏｃｏｃｃｕｓ）株 |
| WO2004046346A2 (en) | 2002-11-15 | 2004-06-03 | Vib Vzw | Self-containing lactobacillus strain |
| AU2005215858B2 (en) | 2004-02-24 | 2010-07-15 | Chr. Hansen A/S | Frozen lactic acid bacteria culture of individual pellets |
| CA2567106A1 (en) | 2004-05-18 | 2005-11-24 | Vib Vzw | Self-containing lactobacillus strain |
| WO2006018446A2 (en) * | 2004-08-20 | 2006-02-23 | Actogenix Nv | Method to improve lactococcus preservation |
| ES2626610T3 (es) | 2005-08-30 | 2017-07-25 | Intrexon Actobiotics Nv | Bacterias de ácido láctico productoras del anti-TNF alfa para el tratamiento de la enfermedad inflamatoria intestinal |
| ES2405552T3 (es) | 2005-11-29 | 2013-05-31 | Actogenix N.V. | Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos |
| RU2008147398A (ru) | 2006-05-02 | 2010-06-10 | Актогеникс Н.В. (Be) | Доставка пептидов, связанных с ожирением, через кишечник посредством микроорганизмов |
| CA2672229A1 (en) | 2006-12-14 | 2008-06-19 | Actogenix N.V. | Delivery of binding molecules to induce immunomodulation |
| EP3124614B1 (en) | 2007-01-12 | 2022-06-08 | Intrexon Actobiotics NV | Lactococcus promoters and uses thereof |
| EP2774621B1 (en) * | 2007-01-25 | 2018-01-24 | Intrexon Actobiotics NV | Treatment of immune disease by mucosal delivery of antigens |
| EP2344626B1 (en) | 2008-09-29 | 2017-03-29 | Intrexon Actobiotics NV | Reduced colonization of microbes at the mucosa |
| WO2010124855A1 (en) | 2009-04-30 | 2010-11-04 | Actogenix Nv | Cryoprotectants for freeze drying of lactic acid bacteria |
| BR112014006883A8 (pt) | 2011-09-23 | 2018-06-26 | Actogenix Nv | bactéria gram-positiva não patogênica carecendo de atividade do componente llc do sistema pts celobiose específico (ptcc), medicamento, aditivo alimentar, composição probiótica, ou cultura iniciadora, produto alimentar e métodos |
-
2012
- 2012-09-21 EP EP12772891.3A patent/EP2758512B1/en active Active
- 2012-09-21 JP JP2014531242A patent/JP6117212B2/ja active Active
- 2012-09-21 US US14/346,504 patent/US9458467B2/en active Active
- 2012-09-21 ES ES12772891.3T patent/ES2676707T3/es active Active
- 2012-09-21 DK DK12772891.3T patent/DK2758512T3/en active
- 2012-09-21 HU HUE12772891A patent/HUE038830T2/hu unknown
- 2012-09-21 WO PCT/EP2012/068633 patent/WO2013041672A1/en not_active Ceased
-
2016
- 2016-09-07 US US15/258,433 patent/US10030234B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014527826A5 (enExample) | ||
| CN103620021B (zh) | 新型组合物 | |
| JP2014526266A5 (enExample) | ||
| RU2014116230A (ru) | Модифицированные грамположительные бактерии и их применение | |
| JP5727611B2 (ja) | 生体物質用の乾燥貯蔵安定化組成物 | |
| Pinto et al. | Influence of microencapsulation with sweet whey and prebiotics on the survival of Bifidobacterium-BB-12 under simulated gastrointestinal conditions and heat treatments | |
| JP6889699B2 (ja) | 特定栄養用途のための安定乾燥プロバイオティクス組成物 | |
| CN103004984B (zh) | 一种植物乳杆菌发酵乳及其制备方法 | |
| CN102482635B (zh) | 具有增强稳定性和生存力的包被的脱水微生物 | |
| RU2014151746A (ru) | Штаммы lactobacillus | |
| CN102965321A (zh) | 一种复合乳酸菌冻干粉的制备方法 | |
| CN108368474A (zh) | 没有或几乎没有糖的稳定的干组合物 | |
| KR20200001543A (ko) | 구연산염을 포함하는 유산균 동결 보호용 조성물 | |
| CN108271382A (zh) | 微生物干燥菌体的制造方法 | |
| CN102329759B (zh) | 一种提高嗜酸乳杆菌冻干存活率的方法 | |
| KR20060131854A (ko) | 개별 펠릿의 냉동 유산균 컬쳐 | |
| Kriger et al. | Properties of lactic acid microorganisms: long-term preservation methods. | |
| Liu et al. | Bacterial viability retention in probiotic foods: a review | |
| CN103184183A (zh) | 一种干酪乳杆菌干粉的制备方法 | |
| JP6074799B2 (ja) | 乳酸菌増殖促進剤及びこれを含有するヨーグルト | |
| Santivarangkna | Storage Stability of Probiotic Powder | |
| KR101764095B1 (ko) | 유산균 분말의 제조방법 | |
| Urbański et al. | Influence of whey on viability of Lactobacillus gasseri during freeze-drying process | |
| CN103525704A (zh) | 一种提高乳酸菌冻干存活率的方法 | |
| Tian et al. | Proper cryoprotectants improving properties of L. plantarum LIP-1 microcapsules |